Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $163,912 - $183,445
-843 Reduced 98.48%
13 $2,000
Q2 2023

Jul 13, 2023

BUY
$183.71 - $210.25 $73,851 - $84,520
402 Added 88.55%
856 $179,000
Q1 2023

Apr 26, 2023

BUY
$191.89 - $259.92 $30,702 - $41,587
160 Added 54.42%
454 $91,000
Q4 2022

Feb 03, 2023

SELL
$197.11 - $250.07 $1,971 - $2,500
-10 Reduced 3.29%
294 $64,000
Q3 2022

Oct 11, 2022

BUY
$182.44 - $250.54 $3,466 - $4,760
19 Added 6.67%
304 $60,000
Q2 2022

Jul 12, 2022

BUY
$204.13 - $302.4 $14,697 - $21,772
72 Added 33.8%
285 $61,000
Q1 2022

Apr 25, 2022

BUY
$255.51 - $362.11 $15,075 - $21,364
59 Added 38.31%
213 $60,000
Q4 2021

Jan 20, 2022

BUY
$351.38 - $448.68 $34,435 - $43,970
98 Added 175.0%
154 $58,000
Q3 2021

Oct 20, 2021

BUY
$372.64 - $458.3 $20,867 - $25,664
56 New
56 $23,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.66B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sugarloaf Wealth Management, LLC Portfolio

Follow Sugarloaf Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.